New Jersey-based health network Hackensack Meridian Health’s Center for Discovery and Innovation (CDI) has created a rapid response test for diagnosing Covid-19.
The developers hope this will allow for a more effective triage system in hospitals and better control the spread of the disease. More than 127,000 cases of Covid-19 have been confirmed globally, with New Jersey confirming 23 presumptive positives.
The CDI has now received preliminary Emergency Use Authorisation from the US Food and Drug Administration (FDA) to start using the test, which has also been approved by the state Department of Health.
